This quarter’s e-issue focuses on malaria in pregnancy, a critically important topic within the field of malaria prevention and control. The changes that occur in a woman’s body when she becomes pregnant, and particularly to her immune system, leave her especially vulnerable to contracting malaria, and experiencing severe illness. Read more…
Malaria elimination is possible within a generation. But controlling malaria and eliminating malaria are different, and each pose certain challenges. Overcoming the unique challenges of malaria elimination is essential to meeting this goal, and the barriers presented in malaria elimination settings will require different strategies and policies.
A recent study in PLOS Pathogens investigates how Epstein-Barr virus and malaria co-infection may create a lethal combination if the timing is right.
The World Health Organization reported the agency would begin testing a promising malaria vaccine in October to see if it should be used in African countries affected by the parasitic disease.
New research shows how mosquitoes have become so good at finding hosts, like us, for their bloody meals.
The European Federation for Pharmaceutical Sciences (EUFEPS) has awarded the Giorgio Segré Prize to Prof Joel Tarning for his scientific research work on the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in vulnerable populations, such as pregnant women and young children.
WHO Member States today agreed a new global malaria strategy for 2016-2030 and approved the Organization’s proposed program budget for 2016-2017. The strategy aims to reduce the global disease burden by 40% by 2020, and by at least 90% by 2030. It also aims to eliminate malaria in at least 35 new countries by 2030.